- Why diversity and inclusion in clinical trials are crucial?
- Understanding critical barriers to minority and underserved patient communities participation in clinical trials
- Equity and Inclusion of Rare Disease Patients – A Must on Many Levels
- What can the industry do to promote more diversity in the future?
- Latest guidelines that make healthcare more inclusive
Moderator:
Gunnar Schroefel, Senior Director Global Patient Advocacy, Daiichi Sankyo
Panelists:
Ify Osunkwo, Chief Patient Officer, Novo Nordisk Rare Disease
Naomi Litchfield, Director, Patient Advocacy, Bionical Emas
Alfred Samuels, Patient Advocate, Inspirational Author, Mentor, and Public Speaker
Amy Yarker, Senior Business Development Manager, NIHR Research
Nikul Bakshi, Research Involvement Lead, Parkinson’s UK